Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[HIV: Social perspective from cinematography. Health education model for infectious diseases in Primary Care].

Atencion primaria·2024
Same author

Molecular characterization of a new N-acetylneuraminate synthase (NeuB1) from Idiomarina loihiensis.

Glycobiology·2014
Same author

Characterization of a novel N-acetylneuraminate lyase from Staphylococcus carnosus TM300 and its application to N-acetylneuraminic acid production.

Journal of agricultural and food chemistry·2012
Same author

[Cinema and professional vocation].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica·2012
Same author

[Intra-abdominal infection: key facts].

Enfermedades infecciosas y microbiologia clinica·2010
Same author

First report in Spain of linezolid non-susceptibility in a clinical isolate of Staphylococcus haemolyticus.

International journal of antimicrobial agents·2007

Related Experiment Video

Updated: Jun 6, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

[Available carbapenems: Properties and differences].

María José Fresnadillo Martínez1, María Inmaculada García García, Enrique García Sánchez

  • 1Universidad de Salamanca, España.

Enfermedades Infecciosas Y Microbiologia Clinica
|December 7, 2010
PubMed
Summary
This summary is machine-generated.

Carbapenems are vital antibiotics for severe infections, especially those caused by resistant bacteria. Doripenem exhibits broader activity against challenging pathogens compared to other carbapenems.

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Related Experiment Videos

Last Updated: Jun 6, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Context:

  • Carbapenems represent a critical class of beta-lactam antibiotics.
  • They are essential for treating severe hospital-acquired and community-acquired infections.
  • Their broad spectrum and resistance to beta-lactamases make them crucial for multiresistant Gram-negative bacterial infections.

Purpose:

  • To compare the antimicrobial activity and clinical indications of different carbapenems.
  • To highlight the specific utility of ertapenem and doripenem.

Summary:

  • Carbapenems possess a broad spectrum of activity and resistance to beta-lactamases, making them vital for treating severe infections.
  • While carbapenems share a similar spectrum, differences in antimicrobial activity dictate their clinical use.
  • Ertapenem is indicated for community-acquired infections requiring hospitalization due to its spectrum limitations (e.g., not covering Pseudomonas aeruginosa).
  • Doripenem demonstrates superior intrinsic activity against extended-spectrum beta-lactamase-producing enterobacteria, AmpC P. aeruginosa, Acinetobacter spp., and anaerobic microorganisms.
  • Doripenem also offers favorable pharmacokinetic and safety profiles, similar to other carbapenems.

Impact:

  • Understanding the nuanced differences in carbapenem activity guides optimal antibiotic selection for specific infections.
  • This knowledge is crucial for combating the rise of antimicrobial resistance.
  • Doripenem's enhanced activity profile expands therapeutic options for complex and resistant Gram-negative infections.